ATE299029T1 - Verfahren und zusammensetzungen zur peptidsynthese (t-20) - Google Patents

Verfahren und zusammensetzungen zur peptidsynthese (t-20)

Info

Publication number
ATE299029T1
ATE299029T1 AT99912802T AT99912802T ATE299029T1 AT E299029 T1 ATE299029 T1 AT E299029T1 AT 99912802 T AT99912802 T AT 99912802T AT 99912802 T AT99912802 T AT 99912802T AT E299029 T1 ATE299029 T1 AT E299029T1
Authority
AT
Austria
Prior art keywords
peptides
methods
present
peptide
synthesis
Prior art date
Application number
AT99912802T
Other languages
English (en)
Inventor
Myung-Chol Kang
Brian Bray
Maynard Lichty
Catherine Mader
Gene Merutka
Original Assignee
Trimeris Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/045,920 external-priority patent/US6281331B1/en
Application filed by Trimeris Inc filed Critical Trimeris Inc
Application granted granted Critical
Publication of ATE299029T1 publication Critical patent/ATE299029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99912802T 1998-03-23 1999-03-22 Verfahren und zusammensetzungen zur peptidsynthese (t-20) ATE299029T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/045,920 US6281331B1 (en) 1998-03-23 1998-03-23 Methods and compositions for peptide synthesis
US09/071,877 US6015881A (en) 1998-03-23 1998-05-01 Methods and compositions for peptide synthesis
PCT/US1999/006230 WO1999048513A1 (en) 1998-03-23 1999-03-22 Methods and compositions for peptide synthesis

Publications (1)

Publication Number Publication Date
ATE299029T1 true ATE299029T1 (de) 2005-07-15

Family

ID=26723345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99912802T ATE299029T1 (de) 1998-03-23 1999-03-22 Verfahren und zusammensetzungen zur peptidsynthese (t-20)

Country Status (13)

Country Link
EP (1) EP1071442B9 (de)
JP (1) JP4602547B2 (de)
CN (1) CN100383158C (de)
AT (1) ATE299029T1 (de)
AU (1) AU751358B2 (de)
BR (1) BR9909018A (de)
CA (1) CA2324348C (de)
DE (1) DE69926061T2 (de)
DK (1) DK1071442T3 (de)
ES (1) ES2245505T3 (de)
NZ (1) NZ507083A (de)
TW (1) TWI233931B (de)
WO (1) WO1999048513A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
US6469136B1 (en) 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
CN1255548C (zh) 2001-06-15 2006-05-10 霍夫曼-拉罗奇有限公司 gp41片段的乙酰化
BR0312889A (pt) * 2002-07-24 2005-06-14 Hoffmann La Roche Polipeptìdeo t20 peguilado
EP1701976A2 (de) * 2003-12-31 2006-09-20 F.Hoffmann-La Roche Ag Peptidsynthese und entschützung mit cosolvenz
ATE410437T1 (de) 2003-12-31 2008-10-15 Hoffmann La Roche Verfahren und systeme zur rückgewinnung von peptiden
WO2005063791A2 (en) 2003-12-31 2005-07-14 F. Hoffmann-La Roche Ag Process for peptide synthesis using a reduced amount of deprotection agent
JP4886702B2 (ja) * 2004-12-30 2012-02-29 エフ．ホフマン−ラ ロシュ アーゲー ペプチド中間体断片を使用するペプチドｔ−２０の合成
EP2013223A2 (de) 2006-05-03 2009-01-14 Mallinckrodt Inc. Zusammensetzung und verfahren zur freisetzung geschützter peptide aus einem harz
WO2009014177A1 (ja) * 2007-07-25 2009-01-29 Ajinomoto Co., Inc. ジベンゾフルベン誘導体の淘汰方法
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
CA2707132A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
WO2010016551A1 (ja) * 2008-08-06 2010-02-11 味の素株式会社 ジベンゾフルベンの除去方法
US20110288235A1 (en) * 2008-09-03 2011-11-24 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
US20100081788A1 (en) * 2008-09-03 2010-04-01 Scinopharm Taiwan Ltd. Process for the Preparation of Pramlintide
WO2011095989A2 (en) * 2010-02-04 2011-08-11 Matrix Laboratories Ltd An improved process for the preparation of enfuvirtide
PL219569B1 (pl) * 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
CN103374054B (zh) * 2012-04-28 2014-12-24 上海第一生化药业有限公司 一步法固相合成多肽的方法
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
IL295109A (en) * 2020-02-05 2022-09-01 Lilly Co Eli Resin miners in a serial peptide synthesizer
CN114315957B (zh) * 2021-12-30 2023-07-07 深圳瑞德林生物技术有限公司 一种多肽的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617088B2 (en) * 1986-06-12 1991-11-21 Biogen, Inc. Peptides involved in the pathogenesis of hiv infection
US4787222A (en) * 1986-11-24 1988-11-29 Novatek Medical Inc. Combination lock for blood identification system
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
WO1994028929A1 (en) * 1993-06-07 1994-12-22 Genentech, Inc. Hiv envelope polypeptides
BR9407531A (pt) * 1993-09-11 1997-08-26 Polymun Scient Immunbio Forsch Peptideos que provocam a formação de anticorpos neutralizadores contra cepas de HIV-1 geneticamente divergentes
BR9707409A (pt) * 1996-02-09 1999-04-13 Waleed Danho Sintese de análogo de vip

Also Published As

Publication number Publication date
CN1303299A (zh) 2001-07-11
AU751358B2 (en) 2002-08-15
CA2324348A1 (en) 1999-09-30
CA2324348C (en) 2006-03-14
EP1071442B1 (de) 2005-07-06
DE69926061T2 (de) 2006-06-01
AU3109799A (en) 1999-10-18
EP1071442A4 (de) 2002-06-05
EP1071442A1 (de) 2001-01-31
TWI233931B (en) 2005-06-11
JP4602547B2 (ja) 2010-12-22
DE69926061D1 (de) 2005-08-11
BR9909018A (pt) 2001-10-16
DK1071442T3 (da) 2005-10-24
CN100383158C (zh) 2008-04-23
ES2245505T3 (es) 2006-01-01
EP1071442B9 (de) 2006-01-18
WO1999048513A1 (en) 1999-09-30
JP2002507576A (ja) 2002-03-12
NZ507083A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
DE69926061D1 (de) Verfahren und zusammensetzungen zur peptidsynthese (t-20)
WO2001034635A3 (en) Methods and compositions for peptide synthesis
Butler Dentin matrix proteins
BG103522A (en) Compositions and methods for ob type protein syntheses
ATE357518T1 (de) Verfahren und zusammensetzungen zur inhibierung des neoplastischen zellwachstums
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
ATE353339T1 (de) Verfahren und zusammensetzung zur hemmung des neoplastischen zellwachstums
UA40621C2 (uk) Моноклональне антитіло, гібридомна клітинна лінія, поліпептид (варіанти), фрагмент днк (варіанти), фармацевтична композиція, спосіб одержання моноклонального антитіла
ATE290014T1 (de) Festphasen-peptidsynthese
DK0813545T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Serrate-gener og fremgangsmåde baseret derpå
DZ3482A1 (fr) Secretagogues de l'hormone de croissance
DK0861261T3 (da) Nukleotid- og proteinsekvenser af hvirveldyrs-Delta-gener og fremgangsmåder baseret derpå
AUPR107800A0 (en) Peptide and nucleic acid molecule ii
TW200505471A (en) Casein hydrolysate, method of preparing the same, and use of the same
ATE394482T1 (de) Verfahren und zusammensetzungen für peptid-, protein- und peptidomimetische synthese
JPS58116443A (ja) 新規ペプチドおよびその製法
MXPA02012378A (es) Secuencias de nucleotidos y aminoacidos de factores de oocito para alterar el crecimiento folicular ovarico in vivo in vitro.
WO1999063094A3 (en) Nucleotide and protein sequences of gpr1 and methods based thereon
DE69812597D1 (de) Peptide zur Inhibition von HPV E7 Proteinen
DE60038667D1 (de) De peptide und ihre verwendung
WO2001032845A3 (en) Methods for the preparation of (lipo)peptide synthetases and (lipo)peptides produced therewith
WO2001074847A3 (en) T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer
RU2004103078A (ru) Молекулы иммунного связывания, ингибирующие синцитиальное слияние клеток трофобласта
EP1820859A3 (de) Verfahren und Zusammensetzungen zur Hemmung des neoplastischen Zellenwachstums
WO2003089461A3 (en) Purified dutpase from helicobacter pylori

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1071442

Country of ref document: EP